MktsMarkets

Atrium Therapeutics, Inc.
NASDAQ: RNAKey statistics
RNA News
Stories mentioning RNA from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q1 '25Mar 31 |
|---|---|---|
| Income Statement | ||
| Revenue | 19,635 | 1,573 |
| Cost of Goods Sold | ||
| Gross Profit | ||
| Operating Expenses | ||
| Research & Development | 16,657 | 6,937 |
| Sales General & Admin | ||
| Total Operating Expenses | 36,915 | 9,025 |
| Operating Income (Loss) | (17,280) | (7,452) |
| Interest Income | ||
| Interest Expense | ||
| Other Expense | ||
| Pretax Income | ||
| Tax Provision | ||
| Net Income (Loss) | (16,633) | (7,449) |
| Earnings Per Share (Basic) | (0.97) | (0.44) |
| Earnings Per Share (Diluted) | (0.97) | (0.44) |
| Weighted Average Shares Outstanding (Basic) | 17,106 | 17,106 |
| Weighted Average Shares Outstanding (Diluted) | 17,106 | 17,106 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About RNA
Atrium Therapeutics, Inc. (NASDAQ: RNA) is a stock listed on the Nasdaq Stock Market under the ticker symbol RNA. It last traded at $6.98 (Nov 19, 2026, 4:00 PM ET), up 5.1% on the day. That gives Atrium Therapeutics a market capitalisation of $143.2M.
Over the past 52 weeks RNA has traded between $6.36 and $73.06.
Revenue for the quarter ended Mar 31, 2026 was $19.6M; a net loss of $16.6M. Revenue was up 1148% from $1.6M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $19.6M | -$16.6M | -84.7% |
| Mar 31, 2025 | $1.6M | -$7.4M | -473.6% |
From Atrium Therapeutics’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…